(Q43793648)

26 November 2017

An inflammatory drug prospect (English)

1 reference

26 November 2017

De Strooper B

1

1 reference

26 November 2017

König G

series ordinal

2

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

26 November 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

Nature

1 reference

26 November 2017

414

1 reference

26 November 2017

6860

1 reference

26 November 2017

159-160

1 reference

https://scigraph.springernature.com/pub.10.1038/35102656

26 November 2017

0 references

cites work

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

21 January 2018

1 reference

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

Secretases as therapeutic targets for the treatment of Alzheimer's disease

21 January 2018

1 reference

Translating cell biology into therapeutic advances in Alzheimer's disease

21 January 2018

1 reference

A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain

21 January 2018

1 reference

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1

21 January 2018

1 reference

Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

21 January 2018

1 reference

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Inflammation and Alzheimer's disease

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/35102656

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference